VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China ...Middle East

PR Newswire - News
VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China
SHANGHAI, March 7, 2024 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, today announced that the Biologics License Application (BLA) for Lonapegsomatropin (TransCon hGH) was accepted by the China National Medical...

Hence then, the article about visen announces acceptance of a biologics license application for lonapegsomatropin in china was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News